Show simple item record

Authordc.contributor.authorWolff L., Claudia 
Authordc.contributor.authorAlvarado Muñoz, Rubén es_CL
Authordc.contributor.authorWolff Reyes, Marcelo es_CL
Admission datedc.date.accessioned2010-07-27T20:34:09Z
Available datedc.date.available2010-07-27T20:34:09Z
Publication datedc.date.issued2010
Cita de ítemdc.identifier.citationRev Chil Infect 2010; 27 (1): 65-74en_US
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/128728
Abstractdc.description.abstractDepression is one of the main psychiatric co-morbidities in HIV infection, presenting with a significantly higher prevalence than in the general population (around 35%). Its presence has been associated with poor quality of life, HIV disease progression and poor adherence to antiretroviral therapy. Although antidepressive treatment has demonstrated effectiveness on the management of depressive symptoms, improvement of clinical and laboratory parameters, and enhancement of antiretroviral adherence, depression is frequently under diagnosed and under treated in these patients. We analyzed the main international findings on depression prevalence, risk factors, consequences and management in people with HIV disease.en_US
Lenguagedc.language.isoesen_US
Keywordsdc.subjectHIVen_US
Títulodc.titlePrevalencia, factores de riesgo y manejo de la depresión en pacientes con infección por VIH: Revisión de la literaturaen_US
Title in another languagedc.title.alternativeDepression in HIV infection: Prevalence, risk factors and managementen_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record